Alkermes
ALKS
#2181
Rank
S$11.76 B
Marketcap
S$70.61
Share price
5.53%
Change (1 day)
89.59%
Change (1 year)

Alkermes (ALKS) - Total assets

Total assets on the balance sheet as of March 2026 : S$5.50 Billion

According to Alkermes's latest financial reports the company's total assets are S$5.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alkermes - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$3.19 B14.28%
2024-12-31S$2.79 B-0.97%
2023-12-31S$2.82 B7.16%
2022-12-31S$2.63 B-3.8%
2021-12-31S$2.73 B6.11%
2020-12-31S$2.57 B5.97%
2019-12-31S$2.43 B-2.38%
2018-12-31S$2.49 B3.72%
2017-12-31S$2.40 B-3.8%
2016-12-31S$2.49 B-4.81%
2015-12-31S$2.62 B3.52%
2014-12-31S$2.53 B
2013-03-31S$1.82 B1.17%
2012-03-31S$1.80 B216.36%
2011-03-31S$0.57 B-20.86%
2010-03-31S$0.72 B-16.27%
2009-03-31S$0.86 B-4.94%
2008-03-31S$0.90 B4.93%
2007-03-31S$0.86 B11.09%
2006-03-31S$0.77 B38.17%
2005-03-31S$0.56 B24.57%
2004-03-31S$0.45 B-0.08%
2003-03-31S$0.45 B-30.2%
2002-03-31S$0.64 B-8.94%
2001-03-31S$0.71 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$259.90 B 4,617.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$153.34 B 2,683.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$268.60 B 4,775.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$191.70 B 3,379.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$111.87 B 1,930.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$147.50 B 2,577.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S$0.10 B-98.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$51.80 B 840.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel